Prophylactic pacemaker implantation in familial amyloid polyneuropathy

Heart Rhythm

Volumn 9, Issue 7, 2012, Pages 1069-1075

  Algalarrondo, Vincent ^a,b   Dinanian, Sylvie ^a,b   Juin, Christophe ^a,b   Chemla, Denis ^a   Bennani, Soumiya L ^a,b   Sebag, Claude ^a,b   Planté, Violaine ^c   Le Guludec, Dominique ^d   Samuel, Didier ^a,e   Adams, David ^a,f   Slama, Michel S ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

^e HÔPITAL PAUL BROUSSE   (France)

^f BICÊTRE HOSPITAL   (France)

Author keywords

Electrocardiography; Familial amyloid polyneuropathy; Pacing; Sudden death

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIAC PATIENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOCUMENTATION; ELECTROCARDIOGRAM; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK REDUCTION; WENCKEBACH PERIOD;

ADULT; AGED; AMYLOID NEUROPATHIES, FAMILIAL; ARRHYTHMIAS, CARDIAC; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES;

EID: 84863097701     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.02.033     Document Type: Article

References (24)

1. Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis 2010;52: 347-361.
2. Eriksson P, Karp K, Bjerle P, Olofsson BO. Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy. Br Heart J 1984;51: 658-662. (Pubitemid 14105282)
3. Anzai N, Akiyama K, Tsuchida K, Yamada M, Kito S, Yamamura Y. Treatment by pacemaker in familial amyloid polyneuropathy. Chest 1989;96:80-84. (Pubitemid 19176418)
4. Freitas J, Santos R, Azevedo E, et al. Hemodynamic, autonomic and neurohormonal behaviour of familial amyloidotic polyneuropathy and neurally mediated syncope patients during supine and orthostatic stress. Int J Cardiol 2007;116: 242-248. (Pubitemid 46241486)
5. Delahaye N, Dinanian S, Slama MS, et al. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med 1999;26:416-424. (Pubitemid 29176454)
6. Delahaye N, Le Guludec D, Dinanian S, et al. Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy. Circulation 2001;104:2911-2916. (Pubitemid 33139102)
7. Hornsten R, Pennlert J, Wiklund U, Lindqvist P, Jensen SM, Suhr OB. Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid 2010;17:63-68.
8. Hornsten R, Wiklund U, Olofsson BO, Jensen SM, Suhr OB. Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation 2004;78:112-116.
9. Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256 -2295.
10. Delahaye N, Rouzet F, Sarda L, et al. Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore) 2006;85:229-238. (Pubitemid 44107181)
11. Savoure A, Frohlig G, Galley D, et al. A new dual-chamber pacing mode to minimize ventricular pacing. Pacing Clin Electrophysiol 2005;28:S43-S46. (Pubitemid 40171079)
12. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-596. (Pubitemid 36951371)
13. Benson MD. Partial amino acid sequence homology between an heredofamilial amyloid protein and human plasma prealbumin. J Clin Invest 1981;67:1035-1041. (Pubitemid 11090541)
14. Jacobson DR, Pastore R, Pool S, et al. Revised transthyretin Ile 122 allele frequency in African-Americans. Hum Genet 1996;98:236-238. (Pubitemid 26237513)
15. Eriksson A, Eriksson P, Olofsson BO, Thornell LE. The cardiac atrioventricular conduction system in familial amyloidosis with polyneuropathy: a clinicopathologic study of six cases from Northern Sweden. Acta Pathol Microbiol Immunol Scand A 1983;91:343-349. (Pubitemid 13006437)
16. Eriksson P, Olofsson BO. Pacemaker treatment in familial amyloidosis with polyneuropathy. Pacing Clin Electrophysiol 1984;7:702-706. (Pubitemid 14037686)
17. Ando Y, Yonehara T, Tanaka Y, Tashima K, Uchino M, Ando M. Early pacemaker implantation in patients with familial amyloidotic polyneuropathy. Muscle Nerve 1996;19:1640-1641. (Pubitemid 26412129)
18. Okamoto S, Hornsten R, Obayashi K, Wijayatunga P, Suhr OB. Continuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant). Liver Transpl 2011;17:122-128.
19. Beckman A, Bjerle P, Olofsson BO. Electrocardiographic Findings in Familial Amyloidotic Polyneuropathy. Vol 6. Basel, Switzerland: Karger; 1992.
20. Sattianayagam PT, Hahn AF, Whelan CJ, et al. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant. Eur Heart J first published online October 11, 2011 doi:10.1093/eurheartj/ehr383.
21. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002;40:1645-1652. (Pubitemid 35253643)
22. Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-2671.
23. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-e62. (Pubitemid 351689050)
24. Lin G, Dispenzieri A, Brady PA. Successful termination of a ventricular arrhythmia by implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis: insight into mechanisms of sudden death. Eur Heart J 2010;31:1538.